Table 1. Clinical scoring system used to determine the individualized activity of radioiodine to be administered (Mooney, 1994).
| Score | Severity of clinical signs | Serum total T4 concentration (nmol/l) | Size of goiter | Total score and recommended activity |
|---|---|---|---|---|
| 1 | Mild | < 80 | Palpable with difficulty | <9: <120 MBq |
| 2 | Mild to moderate | <100 | 1.0 × 0.5 cm | 9–12: 120–150 MBq |
| 3 | Moderate | 100–150 | 1.5 × 0.5 cm | >12: 150–180 MBq |
| 4 | Moderate to severe | 150–400 | >1.5 × 0.5 cm | If bilateral disease, the higher end of the dose interval was used |
| 5 | Severe | >400 | Visible to naked eye |